CD44 and gastric cancer: Activated by CHI3L1, CD44 affects the cell cycle, proliferation, differentiation, EMT, and metabolism via Wnt/β-catenin, PI3K/AKT, and ERK signaling pathways, which are crucial for GC progression and metastasis [54–56].